FibroGen, Inc. (KYNB)
NASDAQ · Healthcare
FibroGen, Inc. Revenue 2020–2025
FibroGen, Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- FibroGen, Inc. revenue for the quarter ending March 31, 2026 was 3.7 M, a 36.47% increase year-over-year.
- FibroGen, Inc. revenue for the twelve months ending March 31, 2026 was 7.4 M.
- FibroGen, Inc. annual revenue for 2025 was 6.4 M, a 78.26% decrease from 2024.
- FibroGen, Inc. annual revenue for 2024 was 29.6 M, a 79.95% decrease from 2023.
- FibroGen, Inc. annual revenue for 2023 was 147.8 M, a 4.99% increase from 2022.
- FibroGen, Inc. annual revenue for 2022 was 140.7 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
FibroGen, Inc. Market Cap — FAQ
FibroGen, Inc. (KYNB) market cap over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYNB's market cap history?
The chart and table above show FibroGen, Inc.'s market cap by year and by quarter, including the growth rate.